CS logo
small CS logo
Het Oogziekenhuis Rotterdam

Rotterdam, Netherlands
Eye care center in Rotterdam
Schiedamse Vest 180, 3011 BH Rotterdam

About Het Oogziekenhuis Rotterdam


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Oogziekenhuis Rotterdam
2
ProQR Therapeutics
2
ThromboGenics
2
Bayer
1
Erasmus Medical Center
1
Santhera Pharmaceuticals
1
Total Rows: 7

Clinical Trials at Het Oogziekenhuis Rotterdam


During the past decade, Het Oogziekenhuis Rotterdam conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100002200332200000000110011Started TrialsCompleted Trails201620172018201920202021202201234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy
2004-12-01
2008-11-01
Completed
60
Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
2007-01-01
2009-11-01
Unknown status
500
A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)
2006-12-01
2010-03-01
Completed
51
Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)
2016-05-01
2018-07-01
Completed
219
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
2019-02-19
2022-01-18
Completed
671
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
2019-04-04
2023-03-01
Active, not recruiting
36
Non-proliferative Diabetic Retinopathy Treated With Runcaciguat
2021-03-17
2024-05-28
Recruiting
98
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036

Rows per page:

1–11 of 11

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Het Oogziekenhuis Rotterdam" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Oogziekenhuis Rotterdam" with 2 trials sponsored, "ProQR Therapeutics" with 2 trials sponsored, "ThromboGenics" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Het Oogziekenhuis Rotterdam" #1 collaborator was "Dutch Kidney Foundation" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 2Hoffmann-La Roche: 2Oogziekenhuis Rotterdam: 2Oogziekenhuis Rotterdam: 2ProQR Therapeutics: 2ProQR Therapeutics: 2ThromboGenics: 2ThromboGenics: 2Bayer: 1Bayer: 1Erasmus Medical Center: 1Erasmus Medical Center: 1Santhera Pharmaceuticals: 1Santhera Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsDutch Kidney Foundation: 1Dutch Kidney Foundation: 1Pfizer: 1Pfizer: 1

Clinical Trials Conditions at Het Oogziekenhuis Rotterdam


According to Clinical.Site data, the most researched conditions in "Het Oogziekenhuis Rotterdam" are "Eye Diseases" (3 trials), "Eye Diseases, Hereditary" (2 trials), "Eye Disorders Congenital" (2 trials), "Glaucoma" (2 trials) and "Retinal Disease" (2 trials). Many other conditions were trialed in "Het Oogziekenhuis Rotterdam" in a lesser frequency.

Clinical Trials Intervention Types at Het Oogziekenhuis Rotterdam


Most popular intervention types in "Het Oogziekenhuis Rotterdam" are "Drug" (8 trials), "Other" (5 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials), "Microplasmin" (1 trials) and "Paul glaucoma drainage device (GDD)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Het Oogziekenhuis Rotterdam


The vast majority of trials in "Het Oogziekenhuis Rotterdam" are 11 trials for "All" genders.

Clinical Trials Status at Het Oogziekenhuis Rotterdam


Currently, there are NaN active trials in "Het Oogziekenhuis Rotterdam". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Het Oogziekenhuis Rotterdam, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Het Oogziekenhuis Rotterdam, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 5Phase 2: 5Phase 3: 4Phase 3: 4Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Active, not recruiting: 3Active, not recruiting: 3Recruiting: 3Recruiting: 3Unknown status: 1Unknown status: 1